test

Michael Kramarz

@Commodore Capital Lp

Latest period2024 - Q3ReportedManaged Assets$1.6BTotal holdings36
Assets growth rate9.24%Assets growth rate (2-Q avg)3.6%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Commodore Capital Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 36 positions.

Assets under management

The assets under management (AUM) of Commodore Capital Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.6B in assets, with a quarterly growth rate of 9.24% and a 2-quarter average growth rate of 3.6%. The portfolio is managed by Michael Kramarz, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
VRDNViridian Therapeutics Inc
Recent Activity
Increased 0.88%
3.63%
$58.015M
2.55M shares@ $22.75 avg price
CLDXCelldex Therapeutics Inc New
Recent Activity
Increased 13.61%
3.44%
$55.028M
1.619M shares@ $34.0 avg price
MNMDMind Medicine Mindmed Inc
Recent Activity
Increased 11.96%
2.85%
$45.52M
8M shares@ $5.69 avg price
CATXPerspective Therapeutics Inc
Recent Activity
Decreased -28.07%
2.8%
$44.723M
3.35M shares@ $13.35 avg price
NRIXNurix Therapeutics Inc
Recent Activity
New Position
2.32%
$37.076M
1.65M shares@ $22.47 avg price
PHVSPharvaris N V
Recent Activity
Increased 5.6%
2.22%
$35.4M
1.911M shares@ $18.52 avg price
KURAKura Oncology Inc
Recent Activity
Increased 12.97%
2.2%
$35.172M
1.8M shares@ $19.54 avg price
RYTMRhythm Pharmaceuticals Inc
Recent Activity
Decreased -46.93%
2.13%
$34.053M
650,000 shares@ $52.39 avg price
ORKAOruka Therapeutics Inc
Recent Activity
New Position
2.1%
$33.572M
1.37M shares@ $24.51 avg price
ARVNArvinas Inc
Recent Activity
Decreased -36.31%
1.85%
$29.556M
1.2M shares@ $24.63 avg price